0000950142-19-001715.txt : 20190808
0000950142-19-001715.hdr.sgml : 20190808
20190807202606
ACCESSION NUMBER: 0000950142-19-001715
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190630
FILED AS OF DATE: 20190808
DATE AS OF CHANGE: 20190807
EFFECTIVENESS DATE: 20190808
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aisling Capital LLC
CENTRAL INDEX KEY: 0001571076
IRS NUMBER: 010849048
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15878
FILM NUMBER: 191007187
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-651-6372
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001571076
XXXXXXXX
06-30-2019
06-30-2019
false
Aisling Capital LLC
888 Seventh Avenue, 12th Floor
New York
NY
10106
13F HOLDINGS REPORT
028-15878
N
Robert Wenzel
Chief Financial Officer
212-651-6374
/s/ Robert Wenzel
New York
NY
08-07-2019
0
4
60338
INFORMATION TABLE
2
infotable.xml
ADMA BIOLOGICS INC
COM
000899104
13964
3608171
SH
SOLE
3608171
0
0
AIMMUNE THERAPEUTICS INC.
COM
00900T107
41432
1990000
SH
SOLE
1990000
0
0
CIDARA THERAPEUTICS INC.
COM
171757107
1716
1021148
SH
SOLE
1021148
0
0
TRANSENTERIX INC.
COM NEW
89366M201
3226
2389352
SH
SOLE
2389352
0
0